-
Mashup Score: 2Norgine seeks approval for high-risk neuroblastoma treatment - 2 day(s) ago
Norgine has sought approval for eflornithine (DFMO) for the treatment of patients with high-risk neuroblastoma (HRNB).
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Gilead's Biktarvy receives FDA expanded approval for HIV - 2 month(s) ago
Gilead Sciences has received FDA approval for an expanded indication for Biktarvy to treat HIV patients with M184V/I resistance mutations.
Categories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0Why patient centricity is the answer to the clinical trial enrolment gap - Pharmaceutical Technology - 3 month(s) ago
Research indicates that designing clinical trials with the patient in mind reduces recruitment times and enhances trial performance.
Categories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 7CAR-T therapies and cancer risk: No easy answers for the FDA - 3 month(s) ago
CAR-T cell therapies can provide durable cancer remission, however, a recent FDA investigation into reports of secondary T-cell malignancies has increased scrutiny of their risk profiles.
Categories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0Memo Therapeutics raises $27.67m for kidney transplant infection trial - Pharmaceutical Technology - 6 month(s) ago
Memo’s fast track-designated candidate is currently in a Phase II trial for BKV infection, with a data readout expected in 2024.
Categories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0ONL Therapeutics seeks upto $100m to further eye disease pipeline - Pharmaceutical Technology - 6 month(s) ago
ONL Therapeutics plans to raise $75-$100m to support Phase II trials in geographic atrophy and open-angle glaucoma.
Categories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1
The subcutaneous Tecentriq has been approved in the UK for all indications that its intravenous counterpart has received approval.
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Artificial intelligence is set to power the future of healthcare provision - Pharmaceutical Technology - 9 month(s) ago
An increasing amount of information make artificial intelligence (AI) stand out as a promising solution to improve the provision of healthcare.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3
Pharmaceutical Technology lists the top five terms tweeted on healthtech in Q3 2021, based on GlobalData’s Healthcare Influencer Platform.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2Antibiotic resistance: how AI can tackle the superbug threat - 2 year(s) ago
Researchers are employing innovative AI methods to combat the growing global threat of antibiotic resistance.
Categories: Healthcare Professionals, Latest HeadlinesTweet
DFMO, developed from @UHCancerCenter, is now expanding its approval for neuroblastoma in the UK, Switzerland, and Australia. Congrats to Dr. Andre Backmann, who is currently at @michiganstateu. https://t.co/b9cHVhXjxZ